TABLE 5.
Clinical adverse events during hospitalization of patients enrolled in 2020 according to reperfusion treatment
| Adverse event | Nonreperfusion group (N = 47) | Reperfusion group (N = 26) | Difference (95% CI) | P value |
|---|---|---|---|---|
| Composite endpoint | 9 (19.2) | 2 (7.7) | 11.5 (−6.7, 29.7) | 0.31 |
| Death | 2 (4.3) | 0 | 4.3 (−4.5, 13.0) | 0.54 |
| Heart failure | 7 (14.9) | 1 (3.9) | 11.1 (−4.5, 26.6) | 0.25 |
| Cardiac arrest | 2 (4.3) | 1 (3.9) | 0.4 (−12.0, 12.8) | 1.00 |
| Cardiac shock | 4 (8.5) | 0 | 8.5 (−2.5, 19.5) | 0.29 |
| Recurrent MI | 6 (12.8) | 1 (3.9) | 8.9 (−6.1, 24.0) | 0.41 |
| Mechanical complication | 0 | 0 | 0 | |
| Arrhythmia | 16 (34.0) | 1 (3.9) | 30.2 (11.8, 48.6) | 0.004 |
Data are presented as n (%). MI, myocardial infarction.